Mireia Arnedo

1.2k total citations
41 papers, 841 citations indexed

About

Mireia Arnedo is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Mireia Arnedo has authored 41 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Virology, 23 papers in Infectious Diseases and 14 papers in Emergency Medicine. Recurrent topics in Mireia Arnedo's work include HIV Research and Treatment (34 papers), HIV/AIDS Research and Interventions (20 papers) and HIV/AIDS drug development and treatment (16 papers). Mireia Arnedo is often cited by papers focused on HIV Research and Treatment (34 papers), HIV/AIDS Research and Interventions (20 papers) and HIV/AIDS drug development and treatment (16 papers). Mireia Arnedo collaborates with scholars based in Spain, United States and Switzerland. Mireia Arnedo's co-authors include Felipe García, José M. Gatell, Tomàs Pumarola, Teresa Gallart, José M. Miró, Cristina Gil‐Sanz, Tuixent Escribà, Montserrat Plana, Anna Cruceta and Gabriel M. Ortiz and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Mireia Arnedo

41 papers receiving 818 citations

Peers

Mireia Arnedo

VIROL

IMMUN

EPIDE

Tzong‐Hae Lee United States

Miguel Genebat Spain

Christina Psomas France

Christophe Baumberger Switzerland

Seema Desai United States

Mariam B. Lawani United States

Mila Lebedeva United States

Stacey A. Rizza United States

Riddhima Banga Switzerland

Natalia Laufer Argentina

Tzong‐Hae Lee United States

Mireia Arnedo

505 ×0.8

VIROL

429 ×0.8

107 ×0.6

196 ×1.5

IMMUN

230 ×2.2

EPIDE

Citations per year, relative to Mireia Arnedo Mireia Arnedo (= 1×) peers Tzong‐Hae Lee

Countries citing papers authored by Mireia Arnedo

Since Specialization

Citations

This map shows the geographic impact of Mireia Arnedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireia Arnedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireia Arnedo more than expected).

Fields of papers citing papers by Mireia Arnedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireia Arnedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireia Arnedo. The network helps show where Mireia Arnedo may publish in the future.

Co-authorship network of co-authors of Mireia Arnedo

This figure shows the co-authorship network connecting the top 25 collaborators of Mireia Arnedo. A scholar is included among the top collaborators of Mireia Arnedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireia Arnedo. Mireia Arnedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fehér, Csaba, Lorna Leal, Montserrat Plana, et al.. (2021). Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals. Vaccines. 9(7). 799–799. 2 indexed citations

Arnedo, Mireia, et al.. (2019). High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay. Journal of Visualized Experiments. 1 indexed citations

Tort, Olivia, Javier García‐Pardo, Tuixent Escribà, et al.. (2018). Versatile iron–catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy. Biomaterials Science. 7(1). 178–186. 24 indexed citations

Tort, Olivia, Tuixent Escribà, Lander Egaña-Gorroño, et al.. (2018). Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed. Journal of Lipid Research. 59(11). 2108–2115. 12 indexed citations

Egaña-Gorroño, Lander, Alberto C. Guardo, Tuixent Escribà, et al.. (2016). MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression. PLoS ONE. 11(5). e0155245–e0155245. 19 indexed citations

Guardo, Alberto C., María J. Maleno, Lander Egaña-Gorroño, et al.. (2016). Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling. Journal of Immunological Methods. 442. 12–19. 7 indexed citations

López-Dupla, Miguel, Elsa Maymó‐Masip, Estebán Martínez, et al.. (2015). HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. PLoS ONE. 10(12). e0144789–e0144789. 5 indexed citations

Egaña-Gorroño, Lander, Tuixent Escribà, Nicolas Boulanger, et al.. (2014). Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors. PLoS ONE. 9(9). e106360–e106360. 46 indexed citations

Torres, Berta, Agathe León, Marta Calvo, et al.. (2013). Rate and Predictors of Non-AIDS Events in a Cohort of HIV-Infected Patients with a CD4 T Cell Count Above 500 Cells/mm ³. AIDS Research and Human Retroviruses. 29(8). 1161–1167. 37 indexed citations

10.

Egaña-Gorroño, Lander, Estebán Martínez, Tuixent Escribà, et al.. (2012). Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients. Frontiers in Immunology. 3. 367–367. 2 indexed citations

11.

Ferreyra, Cecilia, Oliver Yun, Samoel Khamadi, et al.. (2012). Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya. PLoS ONE. 7(11). e49834–e49834. 44 indexed citations

12.

Mallolas, Josep, Pablo Labarga, Antonio Ocampo, et al.. (2007). Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir‐boosted saquinavir. The CIVSA Study^*. HIV Medicine. 8(4). 226–233. 8 indexed citations

13.

Libois, Agnès, Anna Lena Lopez, Felipe García, et al.. (2006). Dynamics of T Cells Subsets and Lymphoproliferative Responses During Structured Treatment Interruption Cycles and After Definitive Interruption of HAART in Early Chronic HIV Type-1-Infected Patients. AIDS Research and Human Retroviruses. 22(7). 657–666. 13 indexed citations

14.

Florence, Éric, Felipe García, Montserrat Plana, et al.. (2004). Long-term Clinical Follow-up, without Antiretroviral Therapy, of Patients with Chronic HIV-1 Infection with Good Virological Response to Structured Treatment Interruption. Clinical Infectious Diseases. 39(4). 569–574. 7 indexed citations

15.

Ferrer, Elena, Daniel Podzamczer, Mireia Arnedo, et al.. (2003). Genotype and Phenotype at Baseline and at Failure in Human Immunodeficiency Virus–Infected Antiretroviral‐Naive Patients in a Randomized Trial Comparing Zidovudine and Lamivudine plus Nelfinavir or Nevirapine. The Journal of Infectious Diseases. 187(4). 687–690. 26 indexed citations

16.

García, Felipe, Montserrat Plana, Mireia Arnedo, et al.. (2003). A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions. AIDS. 17(1). 43–51. 41 indexed citations

17.

García, Felipe, Llúcia Alós, Mireia Arnedo, et al.. (2003). Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy. Antiviral Therapy. 8(6). 635–637. 8 indexed citations

18.

García, Felipe, Montserrat Plana, Gabriel M. Ortiz, et al.. (2001). The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS. 15(9). F29–F40. 155 indexed citations

19.

García, Felipe, Montserrat Plana, Àlex Soriano, et al.. (2001). Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 × 106/l. AIDS. 15(1). 131–133. 8 indexed citations

20.

Martínez, Estebán, Mireia Arnedo, Cristina Gil‐Sanz, et al.. (2001). Lymphoid tissue viral burden and duration of viral suppression in plasma. AIDS. 15(12). 1477–1482. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact